财中社10月23日电绿叶制药（02186）发布公告称，公司计划通过与认购人签署的认购协议发行两期可转换债券，A期债券本金为1亿美元，B期债券本金为5000万美元，均为5.85%利率，预计于2025年到期。此次债券的发行价格为本金的100%。
若债券全部按每股初步换股价3.672港元转换，预计将转化为3.18亿股股份，占公司已发行股本的8.44%。此次融资所得款项净额将用于置换现有债务（约80%），产品研发（约10%），以及一般企业用途（约10%）。预计A期和B期债券的净额分别为9860万美元和4930万美元，转换股份的发售价格净额约为3.62港元。
公司将向新交所申请债券上市，并向联交所申请转换股份上市，交易需满足若干先决条件后方可完成。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.